Covid Cases News LIVE Updates: First day after border reopens, China sees over 2,50,000 arrivals – The Economic Times

China saw about a quarter of a million travelers enter the country on its first day of reopening, though the figure remains a fraction of pre-pandemic flows.

There were 251,045 inbound passenger trips on Sunday, the official Xinhua News agency reported, citing customs data. That compares with a daily average of about 945,300 arrivals in the first quarter of 2019, according to National Immigration Administration data.

The end of quarantine for all arrivals on Sunday marked the end of Covid Zero and China’s long-awaited reopening with the world after three years of isolation. While it’s sparked a flurry of interest among diaspora keen to reunite with loved ones, expensive air fares and still-tight flight capacity mean inbound travel remains difficult for many.

!1 New UpdateClick here for latest updates

First day after border reopens, China sees over 2,50,000 arrivals

China saw about a quarter of a million travelers enter the country on its first day of reopening, though the figure remains a fraction of pre-pandemic flows.

There were 251,045 inbound passenger trips on Sunday, the official Xinhua News agency reported, citing customs data. That compares with a daily average of about 945,300 arrivals in the first quarter of 2019, according to National Immigration Administration data.

Pfizer CEO says there will be no generic Paxlovid for China

Pfizer Inc is not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said on Monday.

Reuters reported on Friday that China was in talks with Pfizer to secure a license that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm’s COVID-19 antiviral drug Paxlovid in China.

Moderna considers pricing COVID vaccine at $110-$130 in USA

Moderna Inc is considering pricing its COVID-19 shot at $110 to $130 per dose in the United States when it shifts from government contracting to commercial distribution of the shots, the company’s Chief Executive Officer Stephane Bancel told the Wall Street Journal on Monday.

Digital medicine to grow by 27% annually

More medical services will be available in the digital realm, meaning that diverse digital technologies ranging from software applications and games will be applied to practices for treatment and the prevention of diseases.

Samjong KPMG’s latest report, which analyzes investment and strategies concerning digital medicine, forecasts that the digital medicine market in Korea will log a 27.2 percent annual level of growth by 2025.

Saudi Arabia removes restrictions on Hajj pilgrim numbers, age limit

Saudi Arabia on Monday announced that there will be no limit on the number of pilgrims for this year’s Hajj, Arab News reported citing the country’s Minister of Hajj and Umrah Tawfiq Al-Rabiah.

Speaking at the Hajj Expo 2023, Tawfiq Al-Rabiah stated that the number of people participating in this year’s Hajj will return to pre-pandemic levels and ther will ne no age limit for Hajj pilgrims this year.

For all the latest world News Click Here 

Read original article here

Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.